Device-Makers Can Help With Cancer ‘Moonshot,' AdvaMed Tells Biden
This article was originally published in The Gray Sheet
Executive Summary
Medical technology plays an important role in cancer treatment and cures via diagnostics and precision medicine, advanced imaging, radiation therapy and surgical oncology, AdvaMed told Vice President Joe Biden in a March 31 letter asking for a meeting with the National Cancer “Moonshot” Task Force.
You may also be interested in...
Industry to Biden: Count Us In On Cancer Moonshot
AdvaMed says the medtech industry needs to at the table to advise the government on investments that could lead to future cancer diagnostics and treatments.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.